| High-dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with coronavirus disease 2019 W Cao, X Liu, T Bai, H Fan, K Hong, H Song, Y Han, L Lin, L Ruan, T Li Open forum infectious diseases 7 (3), ofaa102, 2020 | 508 | 2020 |
| High-dose intravenous immunoglobulins in the treatment of severe acute viral pneumonia: the known mechanisms and clinical effects X Liu, W Cao, T Li Frontiers in immunology 11, 1660, 2020 | 75 | 2020 |
| High-dose intravenous immunoglobulin in severe coronavirus disease 2019: a multicenter retrospective study in China W Cao, X Liu, K Hong, Z Ma, Y Zhang, L Lin, Y Han, Y Xiong, Z Liu, ... Frontiers in immunology 12, 627844, 2021 | 57 | 2021 |
| Prolonged presence of viral nucleic acid in clinically recovered COVID-19 patients was not associated with effective infectiousness K Hong, W Cao, Z Liu, L Lin, X Zhou, Y Zeng, Y Wei, L Chen, X Liu, Y Han, ... Emerging Microbes & Infections 9 (1), 2315-2321, 2020 | 26 | 2020 |
| Comparative transcriptional analysis identified characteristic genes and patterns in HIV-infected immunological non-responders X Liu, L Lin, L Lu, X Li, Y Han, Z Qiu, X Li, Y Li, X Song, W Cao, T Li Frontiers in Immunology 13, 807890, 2022 | 18 | 2022 |
| Comparison of renal function biomarkers of serum creatinine and cystatin C in HIV-infected people on dolutegravir-containing therapy L Lu, X Li, X Liu, Y Han, Z Qiu, X Song, Y Li, X Li, W Cao, T Li Infection and Drug Resistance, 1695-1706, 2022 | 13 | 2022 |
| Combined multi-omics and network pharmacology approach reveals the role of Tripterygium Wilfordii Hook F in treating HIV immunological non-responders X Liu, L Lin, T Lv, L Lu, X Li, Y Han, Z Qiu, X Li, Y Li, X Song, W Cao, T Li Phytomedicine 101, 154103, 2022 | 12 | 2022 |
| Altered plasma metabolites and inflammatory networks in HIV-1 infected patients with different immunological responses after long-term antiretroviral therapy L Lu, Y Yang, Z Yang, Y Wu, X Liu, X Li, L Chen, Y Han, X Song, Z Kong, ... Frontiers in Immunology 14, 1254155, 2023 | 9 | 2023 |
| (5R)-5-hydroxytriptolide for HIV immunological non-responders receiving ART: a randomized, double-blinded, placebo-controlled phase II study W Cao, X Liu, Y Han, X Song, L Lu, X Li, L Lin, L Sun, A Liu, H Zhao, ... The Lancet Regional Health–Western Pacific 34, 2023 | 9 | 2023 |
| Benefits of high-dose intravenous immunoglobulin on mortality in patients with severe COVID-19: An updated systematic review and meta-analysis X Liu, Y Zhang, L Lu, X Li, Y Wu, Y Yang, T Li, W Cao Frontiers in Immunology 14, 1116738, 2023 | 8 | 2023 |
| The pattern and magnitude of T cell subsets reconstitution during ten years of ART with viral suppression in HIV-infected patients L Lu, X Li, X Liu, Z Qiu, Y Han, X Song, Y Li, X Li, W Cao, W Lv, Z Dou, ... Aging (Albany NY) 14 (23), 9647, 2022 | 6 | 2022 |
| Immune Responses to HBV Vaccine in People Living with HIV (PLWHs) Who Achieved Successful Treatment: A Prospective Cohort Study L Xu, L Zhang, S Kang, X Li, L Lu, X Liu, X Song, Y Li, X Li, W Lyu, W Cao, ... Vaccines 11 (2), 400, 2023 | 4 | 2023 |
| HBV pgRNA profiles in Chinese HIV/HBV coinfected patients under pre‐and posttreatment: a multicentre observational cohort study L Xu, X Li, L Lu, X Liu, X Song, Y Li, Y Han, T Zhu, W Cao, T Li Journal of Viral Hepatitis 29 (8), 616-626, 2022 | 4 | 2022 |
| Safety and efficacy of long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection: a systematic review and meta-analysis protocol Y Wu, H Yu, L Lu, X Li, X Liu, W Cao, T Li BMJ open 12 (12), e063089, 2022 | 2 | 2022 |
| Clinical and immunological characteristics of HIV/syphilis co-infected patients following long-term antiretroviral treatment Y Wu, L Lu, X Song, X Liu, Y Yang, L Chen, J Tang, Y Han, W Lv, W Cao, ... Frontiers in Public Health 11, 1327896, 2024 | 1 | 2024 |
| CD4+ T cell counts and soluble programmed death-1 at baseline correlated with hepatitis B surface antigen decline in HIV/HBV coinfection during combined … X Li, L Xu, L Lu, X Liu, Y Yang, Y Wu, Y Han, X Li, Y Li, X Song, W Cao, ... Frontiers in Cellular and Infection Microbiology 13, 1178788, 2023 | 1 | 2023 |
| Differential T-cell profiles determined by Hepatitis B surface antigen decrease among people with Human Immunodeficiency Virus/Hepatitis B Virus coinfection on treatment X Li, L Xu, L Lu, X Liu, Y Yang, Y Wu, T Zhu, X Li, Y Li, X Song, Y Han, ... Journal of Translational Medicine 22 (1), 901, 2024 | | 2024 |
| Peripheral PD-1+NK cells could predict the 28-day mortality in sepsis patients J Tang, C Shang, Y Chang, W Jiang, J Xu, L Zhang, L Lu, L Chen, X Liu, ... Frontiers in Immunology 15, 1426064, 2024 | | 2024 |
| Comprehensive transcriptomic analyses identify the immunosuppressive effects of LLDT-8 in ART-treated SIV-infected rhesus macaques X Liu, T Lv, X Li, J Xue, L Lin, L Lu, X Li, Y Yang, Y Wu, Q Wei, W Cao, T Li International Immunopharmacology 126, 111173, 2024 | | 2024 |
| Cytomegalovirus coinfection among people living with HIV in China before and on cART: A retrospective study X Li, L Lu, X Liu, Y Han, T Zhu, Z Qiu, X Li, Y Li, X Song, W Cao, T Li | | 2022 |
Yuelun ZhangPeking Union Medical College Hospital在 pumch.cn 的电子邮件经过验证
Yuelun ZhangPeking Union Medical College Hospital在 pumch.cn 的电子邮件经过验证
Jean-Pierre RoutyMcGill University Health Centre在 mcgill.ca 的电子邮件经过验证